Doping in Cycling
Interdisciplinary Perspectives
Herausgeber: Fincoeur, Bertrand; Gleaves, John; Ohl, Fabien
50,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
Melden Sie sich
hier
hier
für den Produktalarm an, um über die Verfügbarkeit des Produkts informiert zu werden.
Doping in Cycling
Interdisciplinary Perspectives
Herausgeber: Fincoeur, Bertrand; Gleaves, John; Ohl, Fabien
- Broschiertes Buch
Doping in Cycling provides an up-to-date overview of the knowledge about doping and anti-doping in cycling. Featuring cross-disciplinary contributions from international leading scholars, it critically addresses overarching questions, and topical issues being raised in the agenda of policy-makers at the global level.
Andere Kunden interessierten sich auch für
- Ask Vest ChristiansenGym Culture, Identity and Performance-Enhancing Drugs37,99 €
- Daniel CoyleThe Secret Race9,99 €
- Jie Kang (The College of New Jersey, Ewing, New Jersey, USA)Nutrition and Metabolism in Sports, Exercise and Health75,99 €
- The Psychology of Sport Injury and Rehabilitation36,99 €
- Sports Nutrition for Paralympic Athletes, Second Edition67,99 €
- Exercise Immunology107,99 €
- James WatkinsFundamental Biomechanics of Sport and Exercise58,99 €
-
-
-
Doping in Cycling provides an up-to-date overview of the knowledge about doping and anti-doping in cycling. Featuring cross-disciplinary contributions from international leading scholars, it critically addresses overarching questions, and topical issues being raised in the agenda of policy-makers at the global level.
Produktdetails
- Produktdetails
- Ethics and Sport
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 274
- Erscheinungstermin: 30. September 2020
- Englisch
- Abmessung: 233mm x 156mm x 20mm
- Gewicht: 418g
- ISBN-13: 9780367663858
- ISBN-10: 0367663856
- Artikelnr.: 60018452
- Ethics and Sport
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 274
- Erscheinungstermin: 30. September 2020
- Englisch
- Abmessung: 233mm x 156mm x 20mm
- Gewicht: 418g
- ISBN-13: 9780367663858
- ISBN-10: 0367663856
- Artikelnr.: 60018452
Bertrand Fincoeur is Senior Researcher at the Institute of Sports Sciences at the University of Lausanne, Switzerland. John Gleaves is Associate Professor of Kinesiology at the California State University, Fullerton, USA. Fabien Ohl is Full Professor of Sociology of Sport at the University of Lausanne, Switzerland.
Introduction
PART I: The Use and Supply of Doping Products
1. Assessing and Explaining the Doping Prevalence in Cycling
2. Changing Patterns of Drug Use in Professional Cycling: Implications for Anti-Doping Policy
3. Substance Use
Anti-Doping
and Health in Amateur Cycling
4. The Impact of Scientific Advances on Doping in Cycling
5. Kicked Out: How Experts Are Being Deterred from Playing on the Doping Market
6. The Peculiarities of the Market For Doping Products and the Role of Academic Physicians
PART II: Threats on Cycling and Opportunities for Anti-Doping
7. Doped Humans and Rigged Bikes - And Why We (Wrongly) Get More Upset About the Bikes
8. Everyone Was Doing It: Applying Lessons from Cycling's EPO Era to a Looming TUE Era
9. Cycling Teams Preventing Doping: Can the Fox Guard the Hen House?
10. Blowing the Whistle on Doping in Cycling
11. Performance Data to Improve Cycling's Credibility?
12. What Might a Partially Relaxed Anti-Doping Regime in Professional Cycling Look Like?
PART III: Issues
Controversies and Stakes
13. The Decline of Trust in British Sport Since the London Olympics: Team Sky's Fall from Grace
14. Is Froome's Performance on the 2015 Tour de France Credible? A Sociological Analysis of the Construction of the Performance's Authenticity in Cycling
15. The Clean Corrective: Can Thinking About Clean Cyclists Enhance Anti-Doping?
16. What to do with the TUE Process? Bradley Wiggins
Therapeutic Use and Data Sharing: A Critical Analysis
17. Doping Relevance and the World Anti-Doping Code
PART I: The Use and Supply of Doping Products
1. Assessing and Explaining the Doping Prevalence in Cycling
2. Changing Patterns of Drug Use in Professional Cycling: Implications for Anti-Doping Policy
3. Substance Use
Anti-Doping
and Health in Amateur Cycling
4. The Impact of Scientific Advances on Doping in Cycling
5. Kicked Out: How Experts Are Being Deterred from Playing on the Doping Market
6. The Peculiarities of the Market For Doping Products and the Role of Academic Physicians
PART II: Threats on Cycling and Opportunities for Anti-Doping
7. Doped Humans and Rigged Bikes - And Why We (Wrongly) Get More Upset About the Bikes
8. Everyone Was Doing It: Applying Lessons from Cycling's EPO Era to a Looming TUE Era
9. Cycling Teams Preventing Doping: Can the Fox Guard the Hen House?
10. Blowing the Whistle on Doping in Cycling
11. Performance Data to Improve Cycling's Credibility?
12. What Might a Partially Relaxed Anti-Doping Regime in Professional Cycling Look Like?
PART III: Issues
Controversies and Stakes
13. The Decline of Trust in British Sport Since the London Olympics: Team Sky's Fall from Grace
14. Is Froome's Performance on the 2015 Tour de France Credible? A Sociological Analysis of the Construction of the Performance's Authenticity in Cycling
15. The Clean Corrective: Can Thinking About Clean Cyclists Enhance Anti-Doping?
16. What to do with the TUE Process? Bradley Wiggins
Therapeutic Use and Data Sharing: A Critical Analysis
17. Doping Relevance and the World Anti-Doping Code
Introduction
PART I: The Use and Supply of Doping Products
1. Assessing and Explaining the Doping Prevalence in Cycling
2. Changing Patterns of Drug Use in Professional Cycling: Implications for Anti-Doping Policy
3. Substance Use
Anti-Doping
and Health in Amateur Cycling
4. The Impact of Scientific Advances on Doping in Cycling
5. Kicked Out: How Experts Are Being Deterred from Playing on the Doping Market
6. The Peculiarities of the Market For Doping Products and the Role of Academic Physicians
PART II: Threats on Cycling and Opportunities for Anti-Doping
7. Doped Humans and Rigged Bikes - And Why We (Wrongly) Get More Upset About the Bikes
8. Everyone Was Doing It: Applying Lessons from Cycling's EPO Era to a Looming TUE Era
9. Cycling Teams Preventing Doping: Can the Fox Guard the Hen House?
10. Blowing the Whistle on Doping in Cycling
11. Performance Data to Improve Cycling's Credibility?
12. What Might a Partially Relaxed Anti-Doping Regime in Professional Cycling Look Like?
PART III: Issues
Controversies and Stakes
13. The Decline of Trust in British Sport Since the London Olympics: Team Sky's Fall from Grace
14. Is Froome's Performance on the 2015 Tour de France Credible? A Sociological Analysis of the Construction of the Performance's Authenticity in Cycling
15. The Clean Corrective: Can Thinking About Clean Cyclists Enhance Anti-Doping?
16. What to do with the TUE Process? Bradley Wiggins
Therapeutic Use and Data Sharing: A Critical Analysis
17. Doping Relevance and the World Anti-Doping Code
PART I: The Use and Supply of Doping Products
1. Assessing and Explaining the Doping Prevalence in Cycling
2. Changing Patterns of Drug Use in Professional Cycling: Implications for Anti-Doping Policy
3. Substance Use
Anti-Doping
and Health in Amateur Cycling
4. The Impact of Scientific Advances on Doping in Cycling
5. Kicked Out: How Experts Are Being Deterred from Playing on the Doping Market
6. The Peculiarities of the Market For Doping Products and the Role of Academic Physicians
PART II: Threats on Cycling and Opportunities for Anti-Doping
7. Doped Humans and Rigged Bikes - And Why We (Wrongly) Get More Upset About the Bikes
8. Everyone Was Doing It: Applying Lessons from Cycling's EPO Era to a Looming TUE Era
9. Cycling Teams Preventing Doping: Can the Fox Guard the Hen House?
10. Blowing the Whistle on Doping in Cycling
11. Performance Data to Improve Cycling's Credibility?
12. What Might a Partially Relaxed Anti-Doping Regime in Professional Cycling Look Like?
PART III: Issues
Controversies and Stakes
13. The Decline of Trust in British Sport Since the London Olympics: Team Sky's Fall from Grace
14. Is Froome's Performance on the 2015 Tour de France Credible? A Sociological Analysis of the Construction of the Performance's Authenticity in Cycling
15. The Clean Corrective: Can Thinking About Clean Cyclists Enhance Anti-Doping?
16. What to do with the TUE Process? Bradley Wiggins
Therapeutic Use and Data Sharing: A Critical Analysis
17. Doping Relevance and the World Anti-Doping Code